Industry Initiated Studies
For our industry initiated portfolio we provide several services and centralized processes. All designed to support our pharmaceutical partners in meeting their clinical research expectations.
We commence our site identification process with an in-depth assessment of the feasibility proposal to ensure we can meet the expectations and provide true estimates for project commitments. Following a thorough site identification process, WCN delivers a balanced site list ensuring experience, quality, commitment delivery and highly motivated investigators.
Successfully conducting a clinical trial requires experienced, dedicated and flexible resources. At WCN, we understand the necessity of executing projects within the pre-set timeframe and are organized accordingly. We ensure project engagement by means of a committed study manager and appointed study director, whom collaborate with our site staff. Our team supervises study progress, protocol adherence and mediates with our investigators tackling operational challenges quickly.
Our centralized contract management simplifies and accelerates the contract and budget negotiation processes and also includes centralized investigator payments. WCN uses the national CTA template in all studies.
In addition to these services, we also offer our members online continuous learning GCP training courses as well as an educational program for research professionals. Please note that the courses are provided in Dutch. For an overview of the upcoming courses we refer to our Dutch website or invite you to contact us for more information about training opportunities.